Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.3, a high estimate of $61.00, and a low estimate of $31.00. A 14.64% drop is evident in the current ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge loss for Vertex given that the company has a more advanced type 1 diabetes ...

Masaki Kashiwara has won the 2025 Abel prize, sometimes called the Nobel prize of mathematics, for his work on algebraic analysis. Kashiwara, a professor at Kyoto University, Japan, received the ...